NASDAQ:IOVA
Iovance Biotherapeutics, Inc. Stock News
$10.32
-0.0300 (-0.290%)
At Close: May 21, 2024
Drug used to treat cancer might help reduce COVID-19 severity in patients: Study
11:50am, Saturday, 06'th Jun 2020
Scientists have observed that a drug which is already approved to treat several blood cancers, is associated with reduced respiratory distress and a reduction in the overactive immune response in COVI
Beneath the Ocean’s Surface, a Virus Is Hijacking the Most Abundant Organism on Earth
10:37am, Saturday, 06'th Jun 2020
Rice scientists analyze structure, mechanism of phage protein that steals electrons. Beneath the ocean’s surface, a virus is hijacking the metabolism of the most abundant organism on Earth. That may
You will not forget to take your Medicines anymore: A Daily Call Reminder
07:17am, Saturday, 06'th Jun 2020
A step-by-step guide with implementable code
Telemedicine Is Getting the Boost It Needs to Enter the Future
05:23pm, Friday, 05'th Jun 2020
One of your neighbors posted in Neighbor News. Click through to read what they have to say. (The views expressed in this post are the author’s own.)
BioMarker Strategies Names Greg Bertenshaw Chief Operating and Science Officer
12:00am, Friday, 05'th Jun 2020
BioMarker Strategies, LLC today announced the promotion of Greg Bertenshaw, Ph.D., to Chief Operating and Science Officer, effective immediately.
Why Is Iovance Biotherapeutics (IOVA) Down 1.4% Since Last Earnings Report?
03:31pm, Thursday, 04'th Jun 2020
Iovance Biotherapeutics (IOVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cancer risk for non-daily smokers 4 times higher than non-smokers
04:58pm, Wednesday, 03'rd Jun 2020
Occasional smokers are nearly four times as likely to die from smoking-related cancers as non-smokers, a study published Wednesday has found. Daily smokers are nearly five times as likely to die, rese
Biomedical Scientists Create a New Tool for Developing COVID-19 Treatments & Vaccines
11:59am, Wednesday, 03'rd Jun 2020
Biomedical scientists working with COVID-19 have an important new tool to help them better understand the virus and feel confident about the structural models they are using in their research. Wladek
Hype Collides With Science As FDA Tries To Rein In ‘Wild West’ of COVID Blood Tests
09:00am, Wednesday, 03'rd Jun 2020
Amid questions about the accuracy of the COVID-19 antibody tests flooding the market — and the usefulness of the results they provide — the FDA has belatedly stepped in to try to rein in the chaos
Iovance Biotherapeutics, Inc. Announces Closing of $603.7 Million Common Stock Public Offering
08:01pm, Tuesday, 02'nd Jun 2020
The shares of common stock issued and sold in the offering include 2,540,322 shares issued upon the exercise in full by the underwriters of their option to purchase additional shares at the public off
Iovance Biotherapeutics (IOVA) Upgraded to Buy: Here's What You Should Know
04:00pm, Tuesday, 02'nd Jun 2020
Iovance Biotherapeutics (IOVA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
Mini Human Livers Grown in Lab Successfully Transplanted Into Rats
03:00pm, Tuesday, 02'nd Jun 2020
Using skin cells from human volunteers, researchers at the University of Pittsburgh School of Medicine have created fully functional mini livers, which they then transplanted into rats. In this proof-
New Evidence Suggests Early Spread is Common in Lung and Breast cancers
01:42am, Tuesday, 02'nd Jun 2020
In the context of improving success in lung and breast cancer management, Stanford research points to the seeds of spread being planted…
Hedge Funds Aren’t Done Buying Iovance Biotherapeutics, Inc. (IOVA)
01:20pm, Monday, 01'st Jun 2020
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Ev